- Home
- Publications
- Publication Search
- Publication Details
Title
An Update on Gene Therapy in Parkinson’s Disease
Authors
Keywords
-
Journal
Current Neurology and Neuroscience Reports
Volume 11, Issue 4, Pages 362-370
Publisher
Springer Nature
Online
2011-07-05
DOI
10.1007/s11910-011-0197-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson’s disease
- (2010) Tomas Björklund et al. BRAIN
- Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation
- (2010) S. Thobois et al. BRAIN
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Macrophage-mediated GDNF Delivery Protects Against Dopaminergic Neurodegeneration: A Therapeutic Strategy for Parkinson's Disease
- (2010) KC Biju et al. MOLECULAR THERAPY
- Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
- (2010) Kenneth A. Follett et al. NEW ENGLAND JOURNAL OF MEDICINE
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- (2009) C. W. Olanow et al. NEUROLOGY
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
- EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE
- (2009) Christopher D. Herzog et al. NEUROSURGERY
- Unregulated Cytosolic Dopamine Causes Neurodegeneration Associated with Oxidative Stress in Mice
- (2008) L. Chen et al. JOURNAL OF NEUROSCIENCE
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Transgene Expression, Bioactivity, and Safety of CERE-120 (AAV2-Neurturin) Following Delivery to the Monkey Striatum
- (2008) Christopher D Herzog et al. MOLECULAR THERAPY
- Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
- The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies
- (2008) N. J. Diederich et al. NEUROLOGY
- Treatment of Parkinson’s disease with trophic factors
- (2008) Amie L. Peterson et al. Neurotherapeutics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now